Allergan to Buy MAP for $958 Million

Allergan said it will buy MAP Pharmaceuticals in a $958 million deal that would help the Botox maker expand sales of medical treatments.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news